Pleural mesothelioma (Drug Study-1)
Pleural mesothelioma, a cancer affecting the lining of the lungs, often develops due to exposure to asbestos. Research into treatments for this aggressive disease is ongoing, and drug studies play a crucial role in finding effective therapies. Several drugs and treatment approaches are being investigated in clinical trials for pleural mesothelioma. Here are a few examples:
Immunotherapy: Immunotherapy drugs like pembrolizumab, nivolumab, and ipilimumab, which work by harnessing the body’s immune system to target cancer cells, are being studied in clinical trials for pleural mesothelioma.